MARGARET KREUTZER: Open Payments
NPI 1730836024 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 30 payments from 16 companies in 2025. Trend: 2023 $114 · 2024 $864 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| Janssen Biotech, Inc. | 3 | $81 |
| Incyte Corporation | 2 | $59 |
| Lilly USA, LLC | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 2 | $39 |
| Aveo Pharmaceuticals, Inc. | 1 | $35 |
| Genmab U.S., Inc. | 1 | $30 |
Products named: Vyloy, JAKAFI, VERZENIO, Enhertu, XTANDI, FOTIVDA, RYBREVANT, KISQALI.
Industry payments across CO — which companies pay providers there.
